Details of Drug

Drug General Information (ID: D0890)
Drug Name	Lamotrigine
Drug Type	Small molecule
Drug Synonymous	Crisomet; Labileno; Lamictal; Lamictin; Lamiktal; Lamitor; Lamotrigina; Lamotriginum; Desitin Brand of Lamotrigine; Faes Brand of Lamotrigine; Glaxo Wellcome Brand of Lamotrigine; GlaxoSmithKline Brand of Lamotrigine; Juste Brand of Lamotrigine; Lamictal Cd; Lamictal ODT; Lamictal XR; Lamotrigina [Spanish]; Lamotriginum [Latin]; BW 430C; GI 267119X; GW 273293; L 3791; BW-430C; EUR-1048; Lamictal (TN); Lamictin (TN); Lamotrigine [USAN:INN:BAN]; Lamotrigine (JAN/USAN/INN); 3,5-Diamino-6-(2,3-dichlorophenyl)-1,2,4-triazine; 3,5-Diamino-6-(2,3-dichlorophenyl)-as-triazine; 3,5-diamino-6-(2,3-dichlorophenyl)-as-triazine; 6-(2,3-Dichlorophenyl)-1,2,4-triazine-3,5-diamine; 6-(2,3-Dichlorophenyl)-1,2,4-triazine-3,5-diyldiamine; 6-(2,3-dichlorophenyl)-1,2,4-triazine-3,5-diamine Click to Show/Hide
Disease Class	6A60: Bipolar disorder; 8A61-8A6Z: Epilepsy/seizure
Therapeutic Class	Anticonvulsants
Structure
Structure	3D Structure		2D Structure
Formula	C9H7Cl2N5
InChI	1S/C9H7Cl2N5/c10-5-3-1-2-4(6(5)11)7-8(12)14-9(13)16-15-7/h1-3H,(H4,12,13,14,16)
InChIKey	PYZRQGJRPPTADH-UHFFFAOYSA-N
Canonical SMILES	C1=CC(=C(C(=C1)Cl)Cl)C2=C(N=C(N=N2)N)N
External Link
	Pubchem ID	3878
	CAS Number	84057-84-1
	CHEBI ID	6367
	TTD ID	D03FLC
	INTEDE ID	DR0913
	VARIDT ID	DR00056

Drug-Drug Interaction Network
Sunburst Graph		Legend Information AM001 Affected gastrointestinal absorption AM002 Affected cellular transport AM004 Affected intra/extra-hepatic metabolism AM006 Pharmacodynamic additive effects AM007 Pharmacodynamic antagonistic effects BM003 Complex formation BM009 Altered absorption (Unspecific) BM010 Transporter inhibition BM017 CYP450 enzyme inhibition BM019 UGT inhibition BM023 UGT induction BM026 Increased metabolism (Unspecific) BM038 Additive CNS depression effects BM067 Increased risk of hyponatremia BM075 Increased risk of photosensitivity reactions BM087 Antagonize the effect of antiepileptic agents BM089 Antagonize the effect of antihypertensive agents BM107 Attenuated pharmacological effects (Unspecific)
Relation Graph

Full list of drugs interacting with Lamotrigine
Affected gastrointestinal absorption
	Complex formation					Drug Num: 1
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D0381		Colesevelam	C31H67Cl3N4O	160051	Moderate		Inter Info	[253], [279]
	Altered absorption (Unspecific)					Drug Num: 1
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D1187		Orlistat	C29H53NO5	3034010	Moderate		Inter Info	[295], [53], [296]
Affected cellular transport
	Transporter inhibition					Drug Num: 3
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D0513		Dofetilide	C19H27N3O5S2	71329	Major		Inter Info	[1], [2], [3]
D0412		Dalfampridine	C5H6N2	1727	Moderate		Inter Info	[79], [280], [281]
D1919		Varenicline	C13H13N3	170361	Minor		Inter Info	[53], [286], [283]
Affected intra/extra-hepatic metabolism
	UGT inhibition					Drug Num: 2
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D1677		Valproic acid	C8H16O2	3121	Major		Inter Info	[25], [26], [27], [28], [29], [30], [31], [32], [33], [34], [35], [36], [37], [38], [39], [40], [41], [42], [43], [44], [45], [46], [47], [48]
D0116		Atazanavir	C38H52N6O7	148192	Moderate		Inter Info	[79], [53], [40]
	UGT induction					Drug Num: 7
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D0255		Carbamazepine	C15H12N2O	2554	Moderate		Inter Info	[265], [266], [267], [30], [268], [269], [38], [270], [271], [40], [272], [273], [274], [45], [275]
D0697		Fosphenytoin	C16H15N2O6P	56339	Moderate		Inter Info	[265], [266], [38], [288], [40], [272]
D0948		Lopinavir	C37H48N4O5	92727	Moderate		Inter Info	[79], [293], [283]
D1265		Phenobarbital	C12H12N2O3	4763	Moderate		Inter Info	[265], [266], [38], [288], [40], [272]
D1340		Primidone	C12H14N2O2	4909	Moderate		Inter Info	[265], [266], [38], [288], [40], [272]
D1400		Rifampicin	C43H58N4O12	135398735	Moderate		Inter Info	[300], [286], [283]
D1283		Phenytoin	C15H12N2O2	1775	Moderate		Inter Info	[265], [266], [38], [288], [40], [272]
	Increased metabolism (Unspecific)					Drug Num: 1
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D0688		Folic acid	C19H19N7O6	135398658	Moderate		Inter Info	[259], [260], [261]
Pharmacodynamic additive effects
	Additive CNS depression effects					Drug Num: 165
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D0219		Buprenorphine	C29H41NO4	644073	Major		Inter Info	[4], [5], [6], [7], [8], [9], [10], [11], [12], [13], [14], [15], [16], [17], [18], [19]
D0467		Dextropropoxyphene	C22H29NO2	10100	Major		Inter Info	[20], [21], [22]
D1485		Sodium oxybate	C4H7NaO3	23663870	Major		Inter Info	[23], [24]
D0045		Alprazolam	C17H13ClN4	2118	Moderate		Inter Info	[49], [50], [51]
D0068		Amitriptyline	C20H23N	2160	Moderate		Inter Info	[49], [50], [51]
D0072		Amoxapine	C17H16ClN3O	2170	Moderate		Inter Info	[49], [50], [51]
D0143		Baclofen	C10H12ClNO2	2284	Moderate		Inter Info	[49], [50], [51]
D0160		Benzatropine	C21H25NO	1201549	Moderate		Inter Info	[49], [50], [51]
D0205		Brimonidine (ophthalmic)	C11H10BrN5	2435	Moderate		Inter Info	[52], [53], [54]
D0206		Brimonidine (topical)	C11H10BrN5	2435	Moderate		Inter Info	[52], [53], [54]
D0222		Buspirone	C21H31N5O2	2477	Moderate		Inter Info	[49], [50], [51]
D0224		Butabarbital	C10H16N2O3	2479	Moderate		Inter Info	[49], [50], [51]
D0225		Butalbital	C11H16N2O3	2481	Moderate		Inter Info	[49], [50], [51]
D0263		Carisoprodol	C12H24N2O4	2576	Moderate		Inter Info	[49], [50], [51]
D0305		Cetirizine	C21H25ClN2O3	2678	Moderate		Inter Info	[55], [56]
D0317		Chlordiazepoxide	C16H14ClN3O	2712	Moderate		Inter Info	[49], [50], [51]
D0324		Chlorpromazine	C17H19ClN2S	2726	Moderate		Inter Info	[49], [50], [51]
D0327		Chlorzoxazone	C7H4ClNO2	2733	Moderate		Inter Info	[49], [50], [51]
D0351		Clemastine	C21H26ClNO	26987	Moderate		Inter Info	[49], [50], [51]
D0356		Clobazam	C16H13ClN2O2	2789	Moderate		Inter Info	[49], [50], [51]
D0379		Codeine	C18H21NO3	5284371	Moderate		Inter Info	[49], [50], [51]
D0403		Cyproheptadine	C21H21N	2913	Moderate		Inter Info	[49], [50], [51]
D0456		Dexbrompheniramine	C16H19BrN2	16960	Moderate		Inter Info	[49], [50], [51]
D0466		Dextromethorphan	C18H25NO	5360696	Moderate		Inter Info	[49], [50], [51]
D0532		Doxylamine	C17H22N2O	3162	Moderate		Inter Info	[49], [50], [51]
D0533		Dronabinol	C21H30O2	16078	Moderate		Inter Info	[49], [50], [51]
D0535		Droperidol	C22H22FN3O2	3168	Moderate		Inter Info	[49], [50], [51]
D0612		Eszopiclone	C17H17ClN6O3	969472	Moderate		Inter Info	[49], [50], [51]
D0750		Haloperidol	C21H23ClFNO2	3559	Moderate		Inter Info	[49], [50], [51]
D0776		Hydromorphone	C17H19NO3	5284570	Moderate		Inter Info	[49], [50], [51]
D0795		Imipramine	C19H24N2	3696	Moderate		Inter Info	[49], [50], [51]
D0035		Alfentanil	C21H32N6O3	51263	Moderate		Inter Info	[49], [50], [51]
D0037		Alimemazine	C18H22N2S	5574	Moderate		Inter Info	[49], [50], [51]
D0071		Amobarbital	C11H18N2O3	2164	Moderate		Inter Info	[49], [50], [51]
D0097		Apomorphine	C17H17NO2	6005	Moderate		Inter Info	[262], [263]
D0098		Apraclonidine	C9H10Cl2N4	2216	Moderate		Inter Info	[52], [53], [54]
D0105		Aripiprazole	C23H27Cl2N3O2	60795	Moderate		Inter Info	[49], [50], [51]
D0112		Asenapine	C17H16ClNO	3036780	Moderate		Inter Info	[49], [50], [51]
D0161		Benzhydrocodone	C25H25NO4	49836084	Moderate		Inter Info	[49], [50], [51]
D0183		Biperiden	C21H29NO	2381	Moderate		Inter Info	[49], [50], [51]
D0201		Brexanolone	C21H34O2	92786	Moderate		Inter Info	[264]
D0202		Brexpiprazole	C25H27N3O2S	11978813	Moderate		Inter Info	[49], [50], [51]
D0208		Brivaracetam	C11H20N2O2	9837243	Moderate		Inter Info	[49], [50], [51]
D0212		Bromocriptine	C32H40BrN5O5	31101	Moderate		Inter Info	[49], [50], [51]
D0214		Brompheniramine	C16H19BrN2	6834	Moderate		Inter Info	[49], [50], [51]
D0226		Butorphanol	C21H29NO2	5361092	Moderate		Inter Info	[49], [50], [51]
D0248		Cannabidiol	C21H30O2	644019	Moderate		Inter Info	[49], [50], [51]
D0259		Carbinoxamine	C16H19ClN2O	2564	Moderate		Inter Info	[49], [50], [51]
D0262		Cariprazine	C21H32Cl2N4O	11154555	Moderate		Inter Info	[49], [50], [51]
D0311		Chloral hydrate	C2H3Cl3O2	2707	Moderate		Inter Info	[49], [50], [51]
D0318		Chlormezanone	C11H12ClNO3S	2717	Moderate		Inter Info	[49], [50], [51]
D0322		Chlorphenesin	C9H11ClO3	7697	Moderate		Inter Info	[49], [50], [51]
D0323		Chlorpheniramine	C16H19ClN2	2725	Moderate		Inter Info	[49], [50], [51]
D0359		Clofedanol	C17H20ClNO	2795	Moderate		Inter Info	[49], [50], [51]
D0361		Clomipramine	C19H23ClN2	2801	Moderate		Inter Info	[49], [50], [51]
D0362		Clonazepam	C15H10ClN3O3	2802	Moderate		Inter Info	[49], [50], [51]
D0363		Clonidine	C9H9Cl2N3	2803	Moderate		Inter Info	[49], [50], [51]
D0365		Clorazepic acid	C16H11ClN2O3	2809	Moderate		Inter Info	[49], [50], [51]
D0398		Cyclobenzaprine	C20H21N	2895	Moderate		Inter Info	[49], [50], [51]
D0417		Dantrolene	C14H10N4O5	6914273	Moderate		Inter Info	[49], [50], [51]
D0446		Desipramine	C18H22N2	2995	Moderate		Inter Info	[49], [50], [51]
D0459		Dexmedetomidine	C13H16N2	5311068	Moderate		Inter Info	[49], [50], [51]
D0470		Dezocine	C16H23NO	3033053	Moderate		Inter Info	[49], [50], [51]
D0471		Diamorphine	C21H23NO5	5462328	Moderate		Inter Info	[49], [50], [51]
D0493		Dihydrocodeine	C18H23NO3	5284543	Moderate		Inter Info	[49], [50], [51]
D0502		Diphenhydramine	C17H21NO	3100	Moderate		Inter Info	[49], [50], [51]
D0525		Doxepin	C19H21NO	667477	Moderate		Inter Info	[49], [50], [51]
D0600		Esketamine	C13H16ClNO	182137	Moderate		Inter Info	[79], [282]
D0617		Ethanol	C2H6O	702	Moderate		Inter Info	[283], [284], [285], [53], [286]
D0632		Ezogabine	C16H18FN3O2	121892	Moderate		Inter Info	[49], [50], [51]
D0646		Fentanyl	C22H28N2O	3345	Moderate		Inter Info	[49], [50], [51]
D0662		Flavoxate	C24H25NO4	3354	Moderate		Inter Info	[49], [50], [51]
D0665		Flibanserin	C20H21F3N4O	6918248	Moderate		Inter Info	[287]
D0678		Fluphenazine	C22H26F3N3OS	3372	Moderate		Inter Info	[49], [50], [51]
D0679		Flurazepam	C21H23ClFN3O	3393	Moderate		Inter Info	[49], [50], [51]
D0748		Halazepam	C17H12ClF3N2O	31640	Moderate		Inter Info	[49], [50], [51]
D0772		Hydrocodone	C18H21NO3	5284569	Moderate		Inter Info	[49], [50], [51]
D0781		Hydroxyzine	C21H27ClN2O2	3658	Moderate		Inter Info	[49], [50], [51]
D0791		Iloperidone	C24H27FN2O4	71360	Moderate		Inter Info	[49], [50], [51]
D0853		Isocarboxazid	C12H13N3O2	3759	Moderate		Inter Info	[49], [50], [51]
D0878		Kava	C14H16O3	5281052	Moderate		Inter Info	[49], [50], [51]
D0879		Ketamine	C13H16ClNO	3821	Moderate		Inter Info	[49], [50], [51]
D0897		Lasmiditan	C19H18F3N3O2	11610526	Moderate		Inter Info	[292]
D0901		Lemborexant	C22H20F2N4O2	56944144	Moderate		Inter Info	[49], [50], [51]
D0909		Levacetylmethadol	C23H31NO2	15130	Moderate		Inter Info	[49], [50], [51]
D0917		Levocetirizine	C21H25ClN2O3	1549000	Moderate		Inter Info	[55], [56]
D0923		Levorphanol	C17H23NO	5359272	Moderate		Inter Info	[49], [50], [51]
D0940		Lithium carbonate	CLi2O3	11125	Moderate		Inter Info	[49], [50], [51]
D0942		Lofexidine	C11H12Cl2N2O	30668	Moderate		Inter Info	[49], [50], [51]
D0959		Lumateperone	C24H28FN3O	21302490	Moderate		Inter Info	[49], [50], [51]
D0961		Lurasidone	C28H36N4O2S	213046	Moderate		Inter Info	[49], [50], [51]
D0979		Maprotiline	C20H23N	4011	Moderate		Inter Info	[49], [50], [51]
D1010		Mesoridazine	C21H26N2OS2	4078	Moderate		Inter Info	[49], [50], [51]
D1014		Metaxalone	C12H15NO3	15459	Moderate		Inter Info	[49], [50], [51]
D1046		Metoclopramide	C14H22ClN3O2	4168	Moderate		Inter Info	[49], [50], [51]
D1053		Metyrosine	C10H13NO3	441350	Moderate		Inter Info	[49], [50], [51]
D1060		Midazolam	C18H13ClFN3	4192	Moderate		Inter Info	[49], [50], [51]
D1084		Molindone	C16H24N2O2	23897	Moderate		Inter Info	[49], [50], [51]
D1100		Nalbuphine	C21H27NO4	5311304	Moderate		Inter Info	[49], [50], [51]
D1169		Oliceridine	C22H30N2O2S	66553195	Moderate		Inter Info	[49], [50], [51]
D1172		Olopatadine (nasal)	C21H23NO3	5281071	Moderate		Inter Info	[283], [286], [294]
D1182		Opicapone	C15H10Cl2N4O6	135565903	Moderate		Inter Info	[49], [50], [51]
D1183		Opium	NA	NA	Moderate		Inter Info	[49], [50], [51]
D1188		Orphenadrine	C18H23NO	4601	Moderate		Inter Info	[49], [50], [51]
D1197		Oxazepam	C15H11ClN2O2	4616	Moderate		Inter Info	[49], [50], [51]
D1208		Oxymorphone	C17H19NO4	5284604	Moderate		Inter Info	[49], [50], [51]
D1215		Paliperidone	C23H27FN4O3	115237	Moderate		Inter Info	[49], [50], [51]
D1224		Paraldehyde	C6H12O3	31264	Moderate		Inter Info	[49], [50], [51]
D1247		Pentazocine	C19H27NO	441278	Moderate		Inter Info	[49], [50], [51]
D1252		Pentoxyverine	C20H31NO3	2562	Moderate		Inter Info	[49], [50], [51]
D1255		Pergolide	C19H26N2S	47811	Moderate		Inter Info	[49], [50], [51]
D1257		Perphenazine	C21H26ClN3OS	4748	Moderate		Inter Info	[49], [50], [51]
D1263		Phenelzine	C8H12N2	3675	Moderate		Inter Info	[49], [50], [51]
D1292		Pimozide	C28H29F2N3O	16362	Moderate		Inter Info	[49], [50], [51]
D1352		Promethazine	C17H20N2S	4927	Moderate		Inter Info	[49], [50], [51]
D1355		Propiomazine	C20H24N2OS	4940	Moderate		Inter Info	[49], [50], [51]
D1367		Quazepam	C17H11ClF4N2S	4999	Moderate		Inter Info	[49], [50], [51]
D1378		Ramelteon	C16H21NO2	208902	Moderate		Inter Info	[49], [50], [51]
D1385		Rasagiline	C12H13N	3052776	Moderate		Inter Info	[49], [50], [51]
D1390		Remifentanil	C20H28N2O5	60815	Moderate		Inter Info	[49], [50], [51]
D1431		Rotigotine	C19H25NOS	59227	Moderate		Inter Info	[49], [50], [51]
D1433		Rufinamide	C10H8F2N4O	129228	Moderate		Inter Info	[49], [50], [51]
D1505		Stiripentol	C14H18O3	5311454	Moderate		Inter Info	[49], [50], [51]
D1524		Suvorexant	C23H23ClN6O2	24965990	Moderate		Inter Info	[49], [50], [51]
D1535		Tapentadol	C14H23NO	9838022	Moderate		Inter Info	[49], [50], [51]
D1536		Tasimelteon	C15H19NO2	10220503	Moderate		Inter Info	[49], [50], [51]
D1560		Tetrabenazine	C19H27NO3	6018	Moderate		Inter Info	[49], [50], [51]
D1569		Thalidomide	C13H10N2O4	5426	Moderate		Inter Info	[301]
D1574		Thioridazine	C21H26N2S2	5452	Moderate		Inter Info	[49], [50], [51]
D1576		Thiothixene	C23H29N3O2S2	941651	Moderate		Inter Info	[49], [50], [51]
D1596		Tizanidine	C9H8ClN5S	5487	Moderate		Inter Info	[302]
D1620		Tranylcypromine	C9H11N	19493	Moderate		Inter Info	[49], [50], [51]
D1624		Trazodone	C19H22ClN5O	5533	Moderate		Inter Info	[49], [50], [51]
D1632		Triazolam	C17H12Cl2N4	5556	Moderate		Inter Info	[49], [50], [51]
D1637		Trifluoperazine	C21H24F3N3S	5566	Moderate		Inter Info	[49], [50], [51]
D1644		Trimethobenzamide	C21H28N2O5	5577	Moderate		Inter Info	[49], [50], [51]
D1647		Trimipramine	C20H26N2	5584	Moderate		Inter Info	[49], [50], [51]
D1649		Tripelennamine	C16H21N3	5587	Moderate		Inter Info	[49], [50], [51]
D1673		Valbenazine	C24H38N2O4	24795069	Moderate		Inter Info	[49], [50], [51]
D1675		Valerian	NA	NA	Moderate		Inter Info	[49], [50], [51]
D1694		Vigabatrin	C6H11NO2	5665	Moderate		Inter Info	[49], [50], [51]
D1719		Ziconotide	C102H172N36O32S7	16135415	Moderate		Inter Info	[49], [50], [51]
D0951		Lorazepam	C15H10Cl2N2O2	3958	Moderate		Inter Info	[49], [50], [51]
D0957		Loxapine	C18H18ClN3O	3964	Moderate		Inter Info	[49], [50], [51]
D1001		Meperidine	C15H21NO2	4058	Moderate		Inter Info	[303], [304], [305], [306], [307]
D1005		Meprobamate	C9H18N2O4	4064	Moderate		Inter Info	[49], [50], [51]
D1017		Methadone	C21H27NO	4095	Moderate		Inter Info	[49], [50], [51]
D1023		Methocarbamol	C11H15NO5	4107	Moderate		Inter Info	[49], [50], [51]
D1089		Morphine	C17H19NO3	5288826	Moderate		Inter Info	[49], [50], [51]
D1090		Morphine (liposomal)	C17H19NO3	5288826	Moderate		Inter Info	[49], [50], [51]
D1096		Nabilone	C24H36O3	5284592	Moderate		Inter Info	[49], [50], [51]
D1158		Nortriptyline	C19H21N	4543	Moderate		Inter Info	[49], [50], [51]
D1203		Oxycodone	C18H21NO4	5284603	Moderate		Inter Info	[49], [50], [51]
D1248		Pentobarbital	C11H18N2O3	4737	Moderate		Inter Info	[49], [50], [51]
D1335		Pregabalin	C8H17NO2	5486971	Moderate		Inter Info	[49], [50], [51]
D1347		Procyclidine	C19H29NO	4919	Moderate		Inter Info	[49], [50], [51]
D1351		Promazine	C17H20N2S	4926	Moderate		Inter Info	[49], [50], [51]
D1361		Protriptyline	C19H21N	4976	Moderate		Inter Info	[49], [50], [51]
D1453		Secobarbital	C12H18N2O3	5193	Moderate		Inter Info	[49], [50], [51]
D1547		Temazepam	C16H13ClN2O2	5391	Moderate		Inter Info	[49], [50], [51]
D1616		Tramadol	C16H25NO2	33741	Moderate		Inter Info	[49], [50], [51]
D1638		Triflupromazine	C18H19F3N2S	5568	Moderate		Inter Info	[49], [50], [51]
D1641		Trihexyphenidyl	C20H31NO	5572	Moderate		Inter Info	[49], [50], [51]
D1650		Triprolidine	C19H22N2	5282443	Moderate		Inter Info	[49], [50], [51]
D1729		Zolpidem	C19H21N3O	5732	Moderate		Inter Info	[49], [50], [51]
	Increased risk of hyponatremia					Drug Num: 2
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D0449		Desmopressin	C46H64N14O12S2	5311065	Moderate		Inter Info	[79], [80], [81], [82], [83], [84], [85], [86], [87], [88], [89], [90], [91], [92], [93], [94], [95], [96], [97], [98], [99], [100], [101], [102], [103], [104], [105], [106], [107], [108], [109], [110], [111], [112], [113], [114], [115], [116], [117], [118], [119], [120], [121], [122], [123], [124], [125], [126], [127], [128], [129], [130], [131], [132], [133], [134], [135], [136], [137], [138], [139], [140], [141], [142], [143], [144], [145], [146], [147], [148], [149], [150], [151], [152], [153], [154], [155], [156], [157], [158], [159], [160], [161], [162], [163], [164], [165], [166], [167], [168], [169], [170], [171], [172], [173], [174], [175], [176], [177], [178], [179], [180], [181], [182], [183], [184], [185], [186], [187], [188], [189], [190], [191], [192], [193], [194], [195], [196], [197], [198], [199], [200], [201], [202], [203], [204], [205], [206], [207], [208], [209], [210], [211], [212], [213], [214], [215], [53], [216], [217], [218], [219], [220], [221], [222], [223], [224], [225], [226], [227], [228], [229], [230], [231], [232], [233], [234], [235], [236], [237], [238], [239], [240], [241], [242], [243], [244], [245], [246], [247], [248], [249], [250], [251], [252], [253], [254], [255], [256], [257], [258]
D1683		Vasopressin	C46H65N15O12S2	644077	Moderate		Inter Info	[79], [80], [81], [82], [83], [84], [85], [86], [87], [88], [89], [90], [91], [92], [93], [94], [95], [96], [97], [98], [99], [100], [101], [102], [103], [104], [105], [106], [107], [108], [109], [110], [111], [112], [113], [114], [115], [116], [117], [118], [119], [120], [121], [122], [123], [124], [125], [126], [127], [128], [129], [130], [131], [132], [133], [134], [135], [136], [137], [138], [139], [140], [141], [142], [143], [144], [145], [146], [147], [148], [149], [150], [151], [152], [153], [154], [155], [156], [157], [158], [159], [160], [161], [162], [163], [164], [165], [166], [167], [168], [169], [170], [171], [172], [173], [174], [175], [176], [177], [178], [179], [180], [181], [182], [183], [184], [185], [186], [187], [188], [189], [190], [191], [192], [193], [194], [195], [196], [197], [198], [199], [200], [201], [202], [203], [204], [205], [206], [207], [208], [209], [210], [211], [212], [213], [214], [215], [53], [216], [217], [218], [219], [220], [221], [222], [223], [224], [225], [226], [227], [228], [229], [230], [231], [232], [233], [234], [235], [236], [237], [238], [239], [240], [241], [242], [243], [244], [245], [246], [247], [248], [249], [250], [251], [252], [253], [254], [255], [256], [257], [258]
	Increased risk of photosensitivity reactions					Drug Num: 1
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D1314		Porfimer sodium	C68H74N8O11	135577896	Moderate		Inter Info	[298], [53], [299]
Pharmacodynamic antagonistic effects
	Antagonize the effect of antiepileptic agents					Drug Num: 20
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D0345		Citalopram	C20H21FN2O	2771	Moderate		Inter Info	[57], [58], [59], [60], [61], [62], [63], [64], [53], [65], [66], [67], [68], [69], [70], [71], [72], [73], [74], [75]
D0539		Duloxetine	C18H19NOS	60835	Moderate		Inter Info	[57], [58], [59], [60], [61], [62], [63], [64], [53], [65], [66], [67], [68], [69], [70], [71], [72], [73], [74], [75]
D0676		Fluoxetine	C17H18F3NO	3386	Moderate		Inter Info	[57], [58], [59], [60], [61], [62], [63], [64], [53], [65], [66], [67], [68], [69], [70], [71], [72], [73], [74], [75]
D0687		Fluvoxamine	C15H21F3N2O2	5324346	Moderate		Inter Info	[57], [58], [59], [60], [61], [62], [63], [64], [53], [65], [66], [67], [68], [69], [70], [71], [72], [73], [74], [75]
D0320		Chloroquine	C18H26ClN3	2719	Moderate		Inter Info	[79], [53], [276], [277], [278]
D0451		Desvenlafaxine	C16H25NO2	125017	Moderate		Inter Info	[57], [58], [59], [60], [61], [62], [63], [64], [53], [65], [66], [67], [68], [69], [70], [71], [72], [73], [74], [75]
D0599		Escitalopram	C20H21FN2O	146570	Moderate		Inter Info	[57], [58], [59], [60], [61], [62], [63], [64], [53], [65], [66], [67], [68], [69], [70], [71], [72], [73], [74], [75]
D0779		Hydroxychloroquine	C18H26ClN3O	3652	Moderate		Inter Info	[79], [53], [276], [277], [278]
D1830		Leucovorin	C20H23N7O7	135403648	Moderate		Inter Info	[259], [260], [261]
D1832		Levoleucovorin	C20H23N7O7	135398559	Moderate		Inter Info	[259], [260], [261]
D1833		Levomefolic acid	C20H25N7O6	135398561	Moderate		Inter Info	[259], [260], [261]
D1834		Levomefolic acid (calcium)	C20H25N7O6	135398561	Moderate		Inter Info	[259], [260], [261]
D0920		Levomilnacipran	C15H22N2O	6917779	Moderate		Inter Info	[57], [58], [59], [60], [61], [62], [63], [64], [53], [65], [66], [67], [68], [69], [70], [71], [72], [73], [74], [75]
D1066		Milnacipran	C15H22N2O	65833	Moderate		Inter Info	[57], [58], [59], [60], [61], [62], [63], [64], [53], [65], [66], [67], [68], [69], [70], [71], [72], [73], [74], [75]
D1229		Paroxetine	C19H20FNO3	43815	Moderate		Inter Info	[57], [58], [59], [60], [61], [62], [63], [64], [53], [65], [66], [67], [68], [69], [70], [71], [72], [73], [74], [75]
D1243		Pemoline	C9H8N2O2	4723	Moderate		Inter Info	[79], [53], [297]
D1461		Sertraline	C17H17Cl2N	68617	Moderate		Inter Info	[57], [58], [59], [60], [61], [62], [63], [64], [53], [65], [66], [67], [68], [69], [70], [71], [72], [73], [74], [75]
D1696		Vilazodone	C26H27N5O2	6918314	Moderate		Inter Info	[57], [58], [59], [60], [61], [62], [63], [64], [53], [65], [66], [67], [68], [69], [70], [71], [72], [73], [74], [75]
D1708		Vortioxetine	C18H22N2S	9966051	Moderate		Inter Info	[57], [58], [59], [60], [61], [62], [63], [64], [53], [65], [66], [67], [68], [69], [70], [71], [72], [73], [74], [75]
D1689		Venlafaxine	C17H27NO2	5656	Moderate		Inter Info	[57], [58], [59], [60], [61], [62], [63], [64], [53], [65], [66], [67], [68], [69], [70], [71], [72], [73], [74], [75]
	Antagonize the effect of antihypertensive agents					Drug Num: 1
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D0722		Ginkgo biloba	NA	NA	Moderate		Inter Info	[289], [290], [291]
	Attenuated pharmacological effects (Unspecific)					Drug Num: 22
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D0387		Conjugated estrogens	C18H21NaO5S	45357473	Moderate		Inter Info	[76], [77], [78]
D0388		Conjugated estrogens (topical)	C18H21NaO5S	45357473	Moderate		Inter Info	[76], [77], [78]
D0487		Diethylstilbestrol	C18H20O2	448537	Moderate		Inter Info	[76], [77], [78]
D0626		Etonogestrel	C22H28O2	6917715	Moderate		Inter Info	[76], [77], [78]
D0484		Dienestrol (topical)	C18H18O2	667476	Moderate		Inter Info	[76], [77], [78]
D0536		Drospirenone	C24H30O3	68873	Moderate		Inter Info	[76], [77], [78]
D0605		Esterified estrogens	NA	NA	Moderate		Inter Info	[76], [77], [78]
D0606		Estradiol	C18H24O2	5757	Moderate		Inter Info	[76], [77], [78]
D0607		Estradiol (topical)	C18H24O2	5757	Moderate		Inter Info	[76], [77], [78]
D0608		Estramustine	C23H31Cl2NO3	259331	Moderate		Inter Info	[76], [77], [78]
D0609		Estrone	C18H22O2	5870	Moderate		Inter Info	[76], [77], [78]
D0610		Estrone sulfate	C18H22O5S	3001028	Moderate		Inter Info	[76], [77], [78]
D0611		Estrone sulfate (topical)	C18H22O5S	3001028	Moderate		Inter Info	[76], [77], [78]
D0619		Ethinylestradiol	C20H24O2	5991	Moderate		Inter Info	[76], [77], [78]
D0990		Medroxyprogesterone acetate	C24H34O4	6279	Moderate		Inter Info	[76], [77], [78]
D1011		Mestranol	C21H26O2	6291	Moderate		Inter Info	[76], [77], [78]
D1154		Norethisterone	C20H26O2	6230	Moderate		Inter Info	[76], [77], [78]
D1157		Norgestrel	C21H28O2	13109	Moderate		Inter Info	[76], [77], [78]
D1370		Quinestrol	C25H32O2	9046	Moderate		Inter Info	[76], [77], [78]
D0922		Levonorgestrel	C21H28O2	13109	Moderate		Inter Info	[76], [77], [78]
D1348		Progesterone	C21H30O2	5994	Moderate		Inter Info	[76], [77], [78]
D1349		Progesterone (topical)	C21H30O2	5994	Moderate		Inter Info	[76], [77], [78]

References
1	Product Information. Tikosyn (dofetilide) Pfizer US Pharmaceuticals, Atlanta, GA.
2	Abel S, Nichols DJ, Brearley CJ, Eve MD "Effect of cimetidine and ranitidine on pharmacokinetics and pharmacodynamics of a single dose of dofetilide." Br J Clin Pharmacol 49 (2000): 64-71.[PMID: 10606839]
3	Johnson BF, Cheng SL, Venitz J "Transient kinetic and dynamic interactions between verapamil and dofetilide, a class III antiarrhythmic." J Clin Pharmacol 41 (2001): 1248-56.[PMID: 11697758]
4	Sekar M, Mimpriss TJ "Buprenorphine, benzodiazepines and prolonged respiratory depression." Anaesthesia 42 (1987): 567-8. [PMID: 3592200]
5	Pirnay S, Borron SW, Giudicelli CP, Tourneau J, Baud FJ, Ricordel I "A critical review of the causes of death among post-morten toxicological investigations: analysis of 34 buprenorphine-associated and 35 methadone-associated deaths." Addiction 99 (2004): 978-88. [PMID: 15265095]
6	Schuman-Olivier Z, Hoeppner BB, Weiss RD, Borodovsky J, Shaffer HJ, Albanese MJ "Benzodiazepine use during buprenorphine treatment for opioid dependence: clinical and safety outcomes." Drug Alcohol Depend 132 (2013): 580-6. [PMID: 23688843]
7	Reynaud M, Petit G, Potard D, Courty P "Six deaths linked to concomitant use of buprenorphine and benzodiazepines." Addiction 93 (1998): 1385-92. [PMID: 9926544]
8	Kintz P "A new series of 13 buprenorphine-related deaths." Clin Biochem 35 (2002): 513-6. [PMID: 12493578]
9	Kilicarslan T, Sellers EM "Lack of interaction of buprenorphine with flunitrazepam metabolism." Am J Psychiatry 157 (2000): 1164-6. [PMID: 10873929]
10	Product Information. Suboxone (buprenorphine-naloxone). Reckitt and Colman Pharmaceuticals Inc, Richmond, VA.
11	Reynaud M, Tracqui A, Petit G, Potard D, Courty P "Six deaths linked to misuse of buprenorphine-benzodiazepine combinations." Am J Psychiatry 155 (1998): 448-9. [PMID: 9501765]
12	US Food and Drug Administration "FDA warns about serious risks and death when combining opioid pain or cough medicines with benzodiazepines requires its strongest warning.".
13	Hakkinen M, Launiainen T, Vuori E, Ojanpera I "Benzodiazepines and alcohol are associated with cases of fatal buprenorphine poisoning." Eur J Clin Pharmacol 68 (2012): 301-9. [PMID: 21927835]
14	Gueye PN, Borron SW, Risede P, et al "Buprenorphine and midazolalm act in combination to depress respiration in rats." Toxicol Sci 65 (2002): 107-14. [PMID: 11752690]
15	Tracqui A, Kintz P, Ludes B "Buprenorphine-related deaths among drug addicts in France: a report on 20 fatalities." J Anal Toxicol 22 (1998): 430-4. [PMID: 9788517]
16	Martin HA "The possible consequences of combining lorazepam and buprenorphine/naloxone: a case review." J Emerg Nurs 37 (2011): 200-2. [PMID: 21397143]
17	Center for Substance Abuse Treatment.?Clinical Guidelines for the Use of Buprenorphine in the Treatment of Opioid Addiction. Rockville (MD): Substance Abuse and Mental Health Services Administration (US); 2004. [PMID: 22514846]
18	Ferrant O, Papin F, Clin B, et al "Fatal poisoning due to snorting buprenorphine and alcohol consumption." Forensic Sci Int 204 (2011): e8-11. [PMID: 20554411]
19	Kintz P "Deaths involving buprenorphine: a compendium of French cases." Forensic Sci Int 121 (2001): 65-9. [PMID: 11516889]
20	Hansen BS, Dam M, Brandt J, et al "Influence of dextropropoxyphene on steady state serum levels and protein binding of three anti-epileptic drugs in man." Acta Neurol Scand 61 (1980): 357-67. [PMID: 6998251]
21	Peterson GR, Covault HP, Hostetler RM "Acute inhibition of microsomal drug metabolism by propoxphene in narcotic tolerant/dependent mice." Life Sci 22 (1978): 2087-96. [PMID: 566834]
22	Abernethy DR, Greenblatt DJ, Morse DS, Shader RI "Interaction of propoxyphene with diazepam, alprazolam and lorazepam." Br J Clin Pharmacol 19 (1985): 51-7. [PMID: 2858217]
23	Product Information. Xywav (calcium/magnesium/potass/sodium oxybates). Jazz Pharmaceuticals, Palo Alto, CA.
24	Product Information. Xyrem (sodium oxybate). Orphan Medical, Minnetonka, MN.
25	Anderson GD, Yau MK, Gidal BE, Harris SJ, Levy RH, Lai AA, Wolf KB, Wargin WA, Dren AT "Bidirectional interaction of valproate and lamotrigine in healthy subjects." Clin Pharmacol Ther 60 (1996): 145-56. [PMID: 8823232]
26	Battino D, Croci D, Granata T, Mamoli D, Messina S, Perucca E "Single-dose pharmacokinetics of lamotrigine in children: Influence of age and antiepileptic comedication." Ther Drug Monit 23 (2001): 217-22. [PMID: 11360028]
27	Binnie CD, Debets RM, Engelsman M, Meijer JW, Meinardi H, Overweg J, Peck AW, Van Wieringen A, Yuen WC "Double-blind crossover trial of lamotrigine (Lamictal) as add-on therapy in intractable epilepsy." Epilepsy Res 4 (1989): 222-9. [PMID: 2612495]
28	Binnie CD, van Emde Boas W, Kasteleijn-Nolste-Trenite DG, de Korte RA, Meijer JW, Meinardi H, Miller AA, Overweg J, Peck AW, van Wieringen A "Acute effects of lamotrigine (BW430C) in persons with epilepsy." Epilepsia 27 (1986): 248-54. [PMID: 3698937]
29	Brodie MJ "Lamotrigine." Lancet 339 (1992): 1397-400. [PMID: 1350815]
30	Eriksson AS, Hoppu K, Nergardh A, Boreus L "Pharmacokinetic interactions between lamotrigine and other antiepileptic drugs in children with intractable epilepsy." Epilepsia 37 (1996): 769-73. [PMID: 8764817]
31	Hachad H, Ragueneau-Majlessi I, Levy RH "New antiepileptic drugs: review on drug interactions." Ther Drug Monit 24 (2002): 91-103. [PMID: 11805729]
32	Jawad S, Yuen WC, Peck AW, Hamilton MJ, Oxley JR, Richens A "Lamotrigine: single-dose pharmacokinetics and initial 1 week experience in refractory epilepsy." Epilepsy Res 1 (1987): 194-201. [PMID: 3504397]
33	Magdalou J, Herber R, Bidault R, Siest G "In vitro N-glucuronidation of a novel antiepileptic drug, lamotrigine, by human liver microsomes." J Pharmacol Exp Ther 260 (1992): 1166-73. [PMID: 1545383]
34	Mataringa MI, May TW, Rambeck B "Does lamotrigine influence valproate concentrations?" Ther Drug Monit 24 (2002): 631-6. [PMID: 12352935]
35	Morris RG, Black AB, Lam E, Westley IS "Clinical study of lamotrigine and valproic acid in patients with epilepsy: Using a drug interaction to advantage?." Ther Drug Monit 22 (2000): 656-60. [PMID: 11128232]
36	Page RL, ONeil MG, Yarbrough DR, Conradi S "Fatal toxic epidermal necrolysis related to lamotrigine administration." Pharmacotherapy 18 (1998): 392-8. [PMID: 9545161]
37	Panayiotopoulos CP, Ferrie CD, Knott C, Robinson RO "Interaction of lamotrigine with sodium valproate." Lancet 341 (1993): 445. [PMID: 8094217]
38	Patsalos PN, Froscher W, Pisani F, van Rijn CM "The importance of drug interactions in epilepsy therapy." Epilepsia 43 (2002): 365-385. [PMID: 11952767]
39	Pisani F, Di Perri R, Perucca E, Richens A "Interaction of lamotrigine with sodium valproate." Lancet 341 (1993): 1224. [PMID: 8098122]
40	Product Information. Lamictal (lamotrigine). Glaxo Wellcome, Research Triangle Park, NC.
41	Reutens DC, Duncan JS, Patsalos PN "Disabling tremor after lamotrigine with sodium valproate." Lancet 342 (1993): 185-6. [PMID: 8101290]
42	Riva R, Albani F, Contin M, Baruzzi A "Pharmacokinetic interactions between antiepileptic drugs. Clinical considerations." Clin Pharmacokinet 31 (1996): 470-93. [PMID: 8968658]
43	Sachs B, Ronnau AC, Ruzicka T, Gleichmann E, Schuppe HC "Lamotrigine and toxic epidermal necrolysis." Lancet 348 (1996): 1597. [PMID: 8950920]
44	Sander JW, Patsalos PN, Oxley JR, Hamilton MJ, Yuen WC "A randomised double-blind placebo-controlled add-on trial of lamotrigine in patients with severe epilepsy." Epilepsy Res 6 (1990): 221-6. [PMID: 2272345]
45	Vauzelle-Kervroedan F, Rey E, Cieuta C, et al. "Influence of concurrent antiepileptic medication on the pharmacokinetics of lamotrigine as add-on therapy in epileptic children." Br J Clin Pharmacol 41 (1996): 325-30. [PMID: 8730979]
46	Wadelius M, Karlsson T, Wadelius C, Rane A "Lamotrigine and toxic epidermal necrolysis." Lancet 348 (1996): 1041. [PMID: 8855897]
47	Wong IC, Mawer GE, Sander JW "Factors influencing the incidence of lamotrigine-related skin rash." Ann Pharmacother 33 (1999): 1037-42. [PMID: 10534214]
48	Yuen AW, Land G, Weatherley BC, Peck AW "Sodium valproate acutely inhibits lamotrigine metabolism." Br J Clin Pharmacol 33 (1992): 511-3. [PMID: 1524964]
49	Divoll M, Greenblatt DJ, Lacasse Y, Shader RI "Benzodiazepine overdosage: plasma concentrations and clinical outcome." Psychopharmacology (Berl) 73 (1981): 381-3. [PMID: 6789361]
50	Grabowski BS, Cady WJ, Young WW, Emery JF "Effects of acute alcohol administration on propranolol absorption." Int J Clin Pharmacol Ther Toxicol 18 (1980): 317-9. [PMID: 7429677]
51	Product Information. Belsomra (suvorexant). Merck &amp Company Inc, Whitehouse Station, NJ.
52	Product Information. Alphagan (brimonidine ophthalmic). Allergan Inc, Irvine, CA.
53	Cerner Multum, Inc. "UK Summary of Product Characteristics.".
54	Product Information. Mirvaso (brimonidine topical). Galderma Laboratories Inc, Cranbury, NJ.
55	Product Information. Zyrtec (cetirizine). Pfizer US Pharmaceuticals, New York, NY.
56	Product Information. Xyzal (levocetirizine). UCB Pharma Inc, Smyrna, GA.
57	Belcastro V, Costa C, Striano P "Levetiracetam-associated hyponatremia." Seizure 17 (2008): 389-90. [PMID: 18584781]
58	Gandhi S, McArthur E, Mamdani MM, et.al "Antiepileptic drugs and hyponatremia in older adults: Two population-based cohort studies." Epilepsia 57 (2016): 2067-79. [PMID: 27896804]
59	Product Information. Savella (milnacipran). Forest Pharmaceuticals, St. Louis, MO.
60	Product Information. Aptiom (eslicarbazepine). Sunovion Pharmaceuticals Inc, Marlborough, MA.
61	Product Information. Cymbalta (duloxetine). Lilly, Eli and Company, Indianapolis, IN.
62	Product Information. Pristiq (desvenlafaxine). Wyeth Laboratories, Philadelphia, PA.
63	Product Information. Tegretol (carbamazepine). Novartis Pharmaceuticals, East Hanover, NJ.
64	Product Information. Celexa (citalopram). Forest Pharmaceuticals, St. Louis, MO.
65	Product Information. Paxil (paroxetine). GlaxoSmithKline, Research Triangle Park, NC.
66	Product Information. Prozac (fluoxetine). Dista Products Company, Indianapolis, IN.
67	Product Information. Luvox (fluvoxamine). Solvay Pharmaceuticals Inc, Marietta, GA.
68	Product Information. Effexor (venlafaxine). Wyeth-Ayerst Laboratories, Philadelphia, PA.
69	Product Information. Fetzima (levomilnacipran). Forest Pharmaceuticals, St. Louis, MO.
70	Product Information. Zoloft (sertraline). Roerig Division, New York, NY.
71	Patel KR, Meesala A, Stanilla JK "Sodium valproate-induced hyponatremia: a case report." Prim Care Companion J Clin Psychiatry 12 (2010): epub. [PMID: 21274365]
72	Product Information. Lexapro (escitalopram). Forest Pharmaceuticals, St. Louis, MO.
73	Falhammar H, Lindh JD, Calissendorff J, et.al "Differences in associations of antiepileptic drugs and hospitalization due to hyponatremia: A population-based case-control study." Seizure 59 (2018): 28-33. [PMID: 29730273]
74	Bavbek N, Alkan R, Uz E, Kaftan O, Akcay A "Hyponatremia associated with sodium valproate in a 22-year-old male." Nephrol Dial Transplant 23 (2008): epub. [PMID: 17913733]
75	Product Information. Trileptal (oxcarbazepine) Novartis Pharmaceuticals, East Hanover, NJ.
76	Wilbur K, Ensom MHH "Pharmacokinetic drug interactions between oral contraceptives and second-generation anticonvulsants." Clin Pharmacokinet 38 (2000): 355-65. [PMID: 10803456]
77	Ohman I, Vitols S, Tomson T "Lamotrigine in pregnancy: pharmacokinetics during delivery, in the neonate, and during lactation." Epilepsia 41 (2000): 706-13
78	Sidhu J, Job S, Singh S, Philipson R. The pharmacokinetic and pharmacodynamic consequences of the co-administration of lamotrigine and a combined oral contraceptive in healthy female subjects. Br J Clin Pharmacol. 2006 Feb;61(2):191-9.
79	Cerner Multum, Inc. "Australian Product Information.".
80	Vanhees SL, Paridaens R, Vansteenkiste JF "Syndrome of inappropriate antidiuretic hormone associated with chemotherapy-induced tumour lysis in small-cell lung cancer: case report and literature review." Ann Oncol 11 (2000): 1061-5. [PMID: 11038047]
81	Maramattom BV "Duloxetine-induced syndrome of inappropriate antidiuretic hormone secretion and seizures." Neurology 66 (2006): 773-4. [PMID: 16534127]
82	Kosmidis HV, Bouhoutsou DO, Varvoutsi MC, et al. "Vincristine overdose: experience with 3 patients." Pediatr Hematol Oncol 8 (1991): 171-8. [PMID: 1863543]
83	Miller MG "Tricyclics as a possible cause of hyponatremia in psychiatric patients." Am J Psychiatry 146 (1989): 807. [PMID: 2729439]
84	Kokko H, Hall PD, Afrin LB "Fentanyl-associated syndrome of inappropriate antidiuretic hormone secretion." Pharmacotherapy 22 (2002): 1188-92. [PMID: 12222557]
85	ten Holt WL, van Iperen CE, Schrijver G, Bartelink AK "Severe hyponatremia during therapy with fluoxetine." Arch Intern Med 156 (1996): 681-2. [PMID: 21216670]
86	Nielsen OA, Johannessen AC, Bardrum B "Oxcarbazepine-induced hyponatremia, a cross-sectional study." Epilepsy Res 2 (1988): 269-71. [PMID: 3197696]
87	Schattner A, Skurnik Y "Fluoxetine-induced SIADH." J Am Geriatr Soc 44 (1996): 1413. [PMID: 8909370]
88	Goldstein L, Barker M, Segall F, Asihene R, Balser S, Lautenbach D, Mccoy M "Seizure and transient SIADH associated with sertraline." Am J Psychiatry 153 (1996): 732. [PMID: 8615425]
89	el Weshi A, Thieblemont C, Cottin V, Barbet N, Catimel G "Cisplatin-induced hyponatremia and renal sodium wasting." Acta Oncol 34 (1995): 264-5. [PMID: 7718269]
90	Tanay A, Firemann Z, Yust I, Abramov AL "Chlorpropamide-induced syndrome of inappropriate antidiuretic hormone secretion." J Am Geriatr Soc 29 (1981): 334-6. [PMID: 7240625]
91	Lahr MB "Hyponatremia during carbamazepine therapy." Clin Pharmacol Ther 37 (1985): 693-6. [PMID: 4006369]
92	Catalano G, Kanfer SN, Catalano MC, Alberts VA "The role of sertraline in a patient with recurrent hyponatremia." Gen Hosp Psychiatry 18 (1996): 278-83. [PMID: 8832263]
93	Cohen BJ, Mahelsky M, Adler L "More cases of SIADH with fluoxetine." Am J Psychiatry 147 (1990): 948-9. [PMID: 2356883]
94	Settle EC "Antidepressant drugs: disturbing and potentially dangerous adverse effects." J Clin Psychiatry 59 Suppl 16 (1998): 25-30. [PMID: 9796863]
95	Littlewood TJ, Smith AP "Syndrome of inappropriate antidiuretic hormone secretion due to treatment of lung cancer with cisplatin." Thorax 39 (1984): 636-7. [PMID: 6089367]
96	Jacob S, Spinler SA "Hyponatremia associated with selective serotonin-reuptake inhibitors in older adults." Ann Pharmacother 40 (2006): 1618-22. [PMID: 16896026]
97	Kadowaki T, Hagura R, Kajinuma H, et al "Chlorpropamide-induced hyponatremia: incidence and risk factors." Diabetes Care 6 (1983): 468-71. [PMID: 6443808]
98	Laycock JF, Lewis AF "Potentiation of the response to vasopressin (pitressin) by treatment with a combination of chlorpropamide and chlorothiazide in Brattleboro rats with hereditary hypothalamic diabetes insipidus." Br J Pharmacol 59 (1977): 11-6. [PMID: 836992]
99	Ayonrinde OT, Reutens SG, Sanfilippo FM "Paroxetine-induced SIADH." Med J Aust 163 (1995): 390. [PMID: 7565274]
100	Hamburger S, Langley H, Bowers G "The syndrome of inappropriate secretion of antidiuretic hormone associated with amitriptyline or trifluoperazine administration." J Kans Med Soc 81 (1980): 469-70. [PMID: 7229499]
101	Petersson I, Nilsson G, Hansson B-G, Hedner T "Water intoxication associated with non-steroidal anti-inflammatory drug therapy." Acta Med Scand 221 (1987): 221-3. [PMID: 3591460]
102	Kagawa K, Fujitaka K, Isobe T, et al "Syndrome of inappropriate secretion of ADH (SIADH) following cisplatin administration in a pulmonary adenocarcinoma patient with a malignant pleural effusion." Intern Med 40 (2001): 1020-3. [PMID: 11688826]
103	Gandelman MS "Review of carbamazepine-induced hyponatremia." Prog Neuropsychopharmacol Biol Psychiatry 18 (1994): 211-33. [PMID: 8208974]
104	Ashton MG, Ball SG, Thomas TH, Lee MR "Water intoxication associated with carbamazepine tretment." Br Med J 1 (1977): 1134-5. [PMID: 861500]
105	McCarron M, Wright GD, Roberts SD "Water intoxication after low dose cyclophosphamide." BMJ 311 (1995): 292. [PMID: 7633237]
106	Garrett CA, Simpson TA "Syndrome of inappropriate antidiuretic hormone associated with vinorelbine therapy." Ann Pharmacother 32 (1998): 1306-9. [PMID: 9876812]
107	Stephens WP, Coe JY, Baylis PH "Plasma arginine vasopressin concentrations and antidiuretic action of carbamazepine." Br Med J 1 (1978): 1445-7. [PMID: 647329]
108	Chua TP, Vong SK "Hyponatraemia associated with paroxetine." BMJ 306 (1993): 143. [PMID: 8435627]
109	Giles PD, Seem CC "Dothiepin and water handling." Lancet 2 (1985): 1013. [PMID: 2865482]
110	Luzecky MH, Burman KD, Schultz ER "The syndrome of inappropriate secretion of antidiuretic hormone associated with amitriptyline administration." South Med J 67 (1974): 495-7. [PMID: 4817485]
111	Pledger DR, Mathew H "Hyponatraemia and clomipramine therapy." Br J Psychiatry 154 (1989): 263-4. [PMID: 2775959]
112	Whittaker JA, Parry DH, Bunch C, Weatherall DJ "Coma associated with vincristine therapy." Br Med J 4 (1973): 335-7. [PMID: 4758426]
113	Kosten TR, Camp W "Inappropriate secretion of antidiuretic hormone in a patient receiving piperazine phenothiazines." Psychosomatics 21 (1980): 351,354-5. [PMID: 7384399]
114	Mitsch RA, Lee AK "Syndrome of inappropriate antidiuretic hormone with imipramine." Drug Intell Clin Pharm 20 (1986): 787-9. [PMID: 3769770]
115	Cheung NT, Coley S, Sheeran T, Situnayake RD "Syndrome of inappropriate secretion of antidiuretic hormone induced by diclofenac." BMJ 306 (1993): 186. [PMID: 8443484]
116	Rault RM "Case report: hyponatremia associated with nonsteroidal antiinflammatory drugs." Am J Med Sci 305 (1993): 318-20. [PMID: 8484392]
117	Belton K, Thomas SH "Drug-induced syndrome of inappropriate antidiuretic hormone secretion." Postgrad Med J 75 (1999): 509-10. [PMID: 10646042]
118	Cutting HO "Inappropriate secretion of antidiuretic hormone secondary to vincristine therapy." Am J Med 51 (1971): 269-71. [PMID: 5095530]
119	Bavbek N, Kargili A, Akcay A, Kaya A "Recurrent hyponatremia associated with citalopram and mirtazapine." Am J Kidney Dis 48 (2006): e61-2. [PMID: 16997047]
120	Lichtigfeld FJ, Gillman MA "Dangerous synergism between sedatives and a hyponatraemic state." J R Soc Med 83 (1990): 185. [PMID: 2325062]
121	Product Information. Vasopressin (vasopressin). APP (Abraxis Pharmaceutical Products), Schaumberg, IL.
122	Blacksten JV, Birt JA "Syndrome of inappropriate secretion of antidiuretic hormone secondary to fluoxetine." Ann Pharmacother 27 (1993): 723-4. [PMID: 8329791]
123	Llorente MD, Gorelick M, Silverman MA "Sertraline as the cause of inappropriate antidiuretic hormone secretion." J Clin Psychiatry 55 (1994): 543-4. [PMID: 7814351]
124	Munro AH, Crompton GK "Inappropriate antidiuretic hormone secretion in oat-cell carcinoma of bronchus. Aggravation of hyponatraemia by intravenous cyclophosphamide." Thorax 27 (1972): 640-2. [PMID: 4343447]
125	Gupta AK, Saravay SM "Venlafaxine-induced hyponatremia." J Clin Psychopharmacol 17 (1997): 223-5. [PMID: 9169969]
126	Kinzie BJ "Management of the syndrome of inappropriate secretion of antidiuretic hormone." Clin Pharm 6 (1987): 625-33. [PMID: 3121240]
127	Egger C, Muehlbacher M, Nickel M, Geretsegger C, Stuppaeck C "A case of recurrent hyponatremia induced by venlafaxine." J Clin Psychopharmacol 26 (2006): 439. [PMID: 16855472]
128	Schwab M, Roder F, Morike K, Thon KP, Klotz U "Drug-induced hyponatraemia in elderly patients." Br J Clin Pharmacol 48 (1999): 105-6. [PMID: 10417484]
129	Webberley MJ, Murray JA "Life-threatening acute hyponatraemia induced by low dose cyclophosphamide and indomethacin." Postgrad Med J 65 (1989): 950-2. [PMID: 2616440]
130	Staab JP, Yerkes SA, Cheney EM, Clayton AH "Transient SIADH associated with fluoxetine." Am J Psychiatry 147 (1990): 1569-70. [PMID: 2221175]
131	Girault C, Richard JC, Chevron V, Goulle JP, Droy JM, Bonmarchand G, Leroy J "Syndrome of inappropriate secretion of antidiuretic hormone in two elderly women with elevated serum fluoxetine." J Toxicol Clin Toxicol 35 (1997): 93-5. [PMID: 9022659]
132	Doshi D, Borison R "Association of transient SIADH with sertraline." Am J Psychiatry 151 (1994): 779-80. [PMID: 8166325]
133	Kimura T, Ota K, Shoju M et al "Chlorpropamide-induced ADH release, hyponatremia and central pontine myelinolysis in diabetes mellitus." Tohoku J Exp Med 177 (1995): 303-13. [PMID: 8928190]
134	Bradley ME, Foote EF, Lee EN, Merkle L "Sertraline-associated syndrome of inappropriate antidiuretic hormone: case report and review of the literature." Pharmacotherapy 16 (1996): 680-3. [PMID: 8840376]
135	Matsumura M, Yamaguchi M, Sato T "Severe hyponatremia in a patient treated with levomepromazine and carbamazepine." Intern Med 40 (2001): 459. [PMID: 11393424]
136	Epstein S, Van Mieghem W, Simson E, Jackson WP "Chlorpropamide hyponatremia." N Engl J Med 286 (1972): 785. [PMID: 5025793]
137	Appel WC "Possible roles of normeperidine and hyponatremia in a postoperative death." Can Med Assoc J 137 (1987): 912-3. [PMID: 3676934]
138	Agrawal NK, Rastogi A, Goyal R, Singh SK "Sertraline-induced hyponatremia in the elderly." CJEM 9 (2007): 415. [PMID: 18072985]
139	Jayachandran NV, Chandrasekhara PK, Thomas J, Agrawal S, Narsimulu G "Cyclophosphamide-associated complications: we need to be aware of SIADH and central pontine myelinolysis." Rheumatology 48 (2009): 89-90. [PMID: 18988633]
140	Bouman WP, Johnson H, TrescoliSerrano C, Jones RG "Recurrent hyponatremia associated with sertraline and lofepramine." Am J Psychiatry 154 (1997): 580. [PMID: 9090354]
141	Pillans PI, Coulter DM "Fluoxetine and hyponatraemia - a potential hazard in the elderly." N Z Med J 107 (1994): 85-6. [PMID: 8202292]
142	Sloan RW, Kreider RM, Luderer JR "The effect of chlorpropamide hyponatremia on mental status in a nursing home population." J Fam Pract 16 (1983): 937-42. [PMID: 6842150]
143	Moses AM, Miller M "Drug-induced dilutional hyponatremia." N Engl J Med 291 (1974): 1234-9. [PMID: 4607502]
144	Tomiwa K, Mikawa H, Hazama F, Yazawa K, Hosoya R, Ohya T, Nishimura K "Syndrome of inappropriate secretion of antidiuretic hormone caused by vincristine therapy: a case report of the neuropathology." J Neurol 229 (1983): 267-72. [PMID: 6192229]
145	Robinson D, Brooks J, Mahler E, Sheikh JI "SIADH--compulsive drinking or SSRI influence?" Ann Pharmacother 30 (1996): 885. [PMID: 8826582]
146	Wilkinson TJ, Begg EJ, Winter AC, Sainsbury R "Incidence and risk factors for hyponatraemia following treatment with fluoxetine or paroxetine in elderly people." Br J Clin Pharmacol 47 (1999): 211-7. [PMID: 10190657]
147	Dirks AC, van Hyfte DM "Recurrent hyponatremia after substitution of citalopram with duloxetine." J Clin Psychopharmacol 27 (2007): 313. [PMID: 17502788]
148	Izzedine H, Launay-Vacher V, Ciroldi M, Fardet L, Deray G "Fanconi and inappropriate secretion of antidiuretic hormone syndromes secondary to venlafaxine therapy." Nephron 92 (2002): 944-6. [PMID: 12399647]
149	Smith NJ, Espir ML, Baylis PH "Raised plasma arginine vasopressin concentration in carbamazepine-induced water intoxication." Br Med J 2 (1977): 804. [PMID: 912329]
150	Sarret D, Le Berre JP, Zemraoui N "Tramadol-induced hyponatremia." Am J Kidney Dis 52 (2008): 1026 author reply 1027. [PMID: 18971023]
151	Meynaar IA, Peeters AJ, Mulder AH, Ottervanger JP "Syndrome of inappropriate ADH secretion attributed to the serotonin re-uptake inhibitors, venlafaxine and paroxetine." Neth J Med 50 (1997): 243-5. [PMID: 9232089]
152	Instituto de Salud Pblica de Chile "Sistema de Consulta de Productos Registrados.".
153	Madhusoodanan S, Osnos R "Amitriptyline induced hyponatremia: a case report." Mt Sinai J Med 48 (1981): 431-3. [PMID: 6975430]
154	Degner D, Grohmann R, Kropp S, et al. "Severe adverse drug reactions of antidepressants: results of the German multicenter drug surveillance program AMSP." Pharmacopsychiatry 37 Suppl 1 (2004): S39-45. [PMID: 15052513]
155	Selective serotonin reuptake inhibitors and SIADH. Med J Aust 164 (1996): 562. [PMID: 8649298]
156	Orbo A, Simonsen E "Cisplatin-induced sodium and magnesium wastage." Eur J Cancer 28A (1992): 1294. [PMID: 1627398]
157	Johannessen AC, Nielsen OA "Hyponatremia induced by oxcarbazepine." Epilepsy Res 1 (1987): 155-6. [PMID: 3143548]
158	Kazal LA, Jr Hall DL, Miller LG, Noel ML "Fluoxetine-induced SIADH: a geriatric occurrence?" J Fam Pract 36 (1993): 341-3. [PMID: 8454983]
159	Goddard C, Paton C "Hyponatraemia associated with paroxetine." BMJ 305 (1992): 1332. [PMID: 1483080]
160	Fort S, Bannister P, Manning A, Bolton R, Losowsky MS "Inappropriate antidiuretic hormone secretion associated with dothiepin." Lancet 2 (1985): 551. [PMID: 2863561]
161	Product Information. DDAVP (desmopressin). Rhone-Poulenc Rorer, Collegeville, PA.
162	Vishwanath BM, Navalgund AA, Cusano W, Navalgund KA "Fluoxetine as a cause of SIADH." Am J Psychiatry 148 (1991): 542-3. [PMID: 2006703]
163	Inappropriate antidiuretic hormone secretion. West J Med 122 (1975): 145-9. [PMID: 1114800]
164	Palmer BF, Gates JR, Lader M "Causes and management of hyponatremia." Ann Pharmacother 37 (2003): 1694-702. [PMID: 14565794]
165	Famularo G, Gasbarrone L, De Virgilio A, Minisola G "Mirtazapine-associated hyponatremia in an elderly patient." Ann Pharmacother 43 (2009): 1144-5. [PMID: 19435965]
166	O'Sullivan D, Oyebode F "Hyponatraemia and lofepramine." Br J Psychiatry 150 (1987): 720-1. [PMID: 3651721]
167	Liu BA, Mittmann N, Knowles SR, Shear NH "Hyponatremia and the syndrome of inappropriate secretion of antidiuretic hormone associated with the use of selective serotoni reuptake inhibitors: a review of spontaneous reports [publishe erratum appears in Can Med Assoc J 1996 Oct 15 155(8):1043." CMAJ 155 (1996): 519-27. [PMID: 8804257]
168	Abbott R "Hyponatremia due to antidepressant medications." Ann Emerg Med 12 (1983): 708-10. [PMID: 6638632]
169	Perucca E, Garratt A, Hebdige S, Richens A "Water intoxication in epileptic patients receiving carbamazepine." J Neural Neurosurg Psychiatry 41 (1978): 713-8. [PMID: 681958]
170	Jacob S, Spinler SA. Hyponatremia associated with selective serotonin-reuptake inhibitors in older adults. Ann Pharmacother. 2006;40(9):1618-1622. [PMID: 16896026]
171	Safdieh JE, Rudominer R "A case of hyponatremia induced by duloxetine." J Clin Psychopharmacol 26 (2006): 675-676. [PMID: 17110834]
172	Culine S, Ghosn M, Droz JP "Inappropriate antidiuretic hormone secretion induced by ifosfamide." Eur J Cancer 26 (1990): 922. [PMID: 2145942]
173	Harris RC "Cyclooxygenase-2 inhibition and renal physiology." Am J Cardiol 89(6 Suppl 1) (2002): 10-7. [PMID: 11909556]
174	Product Information. Vasostrict (vasopressin). Par Pharmaceutical Inc, Chestnut Ridge, NY.
175	DeFronzo RA, Braine H, Colvin M, Davis PJ "Water intoxication in man after cyclophosphamide therapy: time course and relation to drug activation." Ann Intern Med 78 (1973): 861-9. [PMID: 4713567]
176	Lazarevic V, Hagg E, Wahlin A "Hiccups and severe hyponatremia associated with high-dose cyclophosphamide in conditioning regimen for allogeneic stem cell transplantation." Am J Hematol 82 (2007): 88. [PMID: 16917917]
177	Levsky ME, Schwartz JB "Sertraline-induced hyponatremia in an older patient." J Am Geriat Soc 46 (1998): 1582-3. [PMID: 9848826]
178	Moses AM, Howanitz J, Miller M "Diuretic action of three sulfonylurea drugs." Ann Intern Med 78 (1973): 541-4. [PMID: 4632790]
179	van Campen JP, Voets AJ "SIADH caused by paroxetine." Ann Pharmacother 30 (1996): 1499. [PMID: 8968470]
180	Fonseca VA, Deb M, Gokani SS, Bhandarkar SD "Chlorpropamide induced syndrome of inappropriate antidiuretic hormone secretion." J Postgrad Med 26 (1980): 127-30. [PMID: 7218172]
181	Weir MR "Renal effects of nonselective NSAIDs and coxibs." Cleve Clin J Med 69(Suppl 1) (2002): SI53-8. [PMID: 12086295]
182	Davis FB, Davis PJ "Water metabolism in diabetes mellitus." Am J Med 70 (1981): 210-4. [PMID: 7457488]
183	Bjorck E, Samuelsson J "Syndrome of inappropriate secretion of antidiuretic hormone (SIADH) after treatment with cyclophosphamide, alpha-interferon and betamethasone in a patient with multiple myeloma." Eur J Haematol 56 (1996): 323-5. [PMID: 8641409]
184	Cilli AS, Algun E "Oxcarbazepine-induced syndrome of inappropriate secretion of antidiuretic hormone." J Clin Psychiatry 63 (2002): 742. [PMID: 12197457]
185	Oldham RK, Pomeroy TC "Vincristine-induced syndrome of inappropriate secretion of antidiuretic hormone." South Med J 65 (1972): 1010-2. [PMID: 4557951]
186	Garson M "Syndrome of dilutional hyponatraemia secondary to tricyclic antidepressant." Practitioner 222 (1979): 411-2. [PMID: 450841]
187	Ortenzi A, Paggi A, Foschi N, Sabbatini D, Pistoli E "Oxcarbazepine and adverse events: impact of age, dosage, metabolite serum concentrations and concomitant antiepileptic therapy." Funct Neurol 23 (2008): 97-100. [PMID: 18671911]
188	Nicholson RG, Feldman W "Hyponatremia in association with vincristine therapy." Can Med Assoc J 106 (1972): 356-7. [PMID: 4501374]
189	John L, Perreault MM, Tao T, Blew PG "Serotonin syndrome associated with nefazodone and paroxetine." Ann Emerg Med 29 (1997): 287-9. [PMID: 9018197]
190	Crews JR, Potts NL, Schreiber J, Lipper S "Hyponatremia in a patient treated with sertraline." Am J Psychiatry 150 (1993): 1564. [PMID: 8379571]
191	Ryan M, Adams AG, Larive LL "Hyponatremia and leukopenia associated with oxcarbazepine following carbamazepine therapy." Am J Health Syst Pharm 58 (2001): 1637-9. [PMID: 11556658]
192	Kalff R, Houtkooper MA, Meyer JW, et al "Carbamazepine and serum sodium levels." Epilepsia 24 (1984): 390-7. [PMID: 6327253]
193	Levin L, Sealy R, Barron J "Syndrome of inappropriate antidiuretic hormone secretion following cis-dichlorodiammineplatinum II in a patient with malignant thymoma." Cancer 50 (1982): 2279-82. [PMID: 6890402]
194	Hamed M, Mitchell H, Clow DJ "Hyponatraemic convulsion associated with desmopressin and imipramine treatment." BMJ 306 (1993): 1169. [PMID: 8499820]
195	Paliwal V, Garg RK, Kar AM, Singh MK "Oxcarbazepine induced hyponatremic coma." Neurol India 54 (2006): 214-5. [PMID: 16804276]
196	Kruger S, Lindstaedt M "Duloxetine and hyponatremia: a report of 5 cases." J Clin Psychopharmacol 27 (2007): 101-104. [PMID: 17224730]
197	Dong X, Leppik IE, White J, Rarick J "Hyponatremia from oxcarbazepine and carbamazepine." Neurology 65 (2005): 1976-8. [PMID: 16380624]
198	Cantwell BM, Idle M, Millward MJ, Hall G, Lind MJ "Encephalopathy with hyponatremia and inappropriate arginine vasopressin secretion following an intravenous ifosfamide infusion." Ann Oncol 1 (1990): 232. [PMID: 2261371]
199	Bourgeois JA "Reversible hyponatremia and venlafaxine." Psychosomatics 46 (2005): 495-6. [PMID: 16145194]
200	Purcell P, Valmana A "Toxic epidermal necrolysis following chlorpromazine ingestion complicated by SIADH." Postgrad Med J 72 (1996): 186-9. [PMID: 8731716]
201	Steinhoff BJ, Stoll KD, Stodieck SR, Paulus W "Hyponatremic coma under oxcarbazepine therapy." Epilepsy Res 11 (1992): 67-70. [PMID: 1563340]
202	Isojarvi JI, Huuskonen UE, Pakarinen AJ, Vuolteenaho O, Myllyla VV "The regulation of serum sodium after replacing carbamazepine with oxcarbazepine." Epilepsia 42 (2001): 741-5. [PMID: 11422328]
203	Okamoto M, Nako Y, Tachibana A, et al "Efficacy of phenytoin against hyponatremic seizures due to SIADH after administration of anticancer drugs in a neonate." J Perinatol 22 (2002): 247-8. [PMID: 11948390]
204	Kuroda H, Kawamura M, Hato T, et al. "Syndrome of inappropriate secretion of antidiuretic hormone after chemotherapy with vinorelbine." Cancer Chemother Pharmacol (2007):. [PMID: 17989977]
205	Henry DA, Lawson DH, Reavey P, Renfrew S "Hyponatraemia during carbamazepine treatment." Br Med J 1 (1977): 83-4. [PMID: 832021]
206	Kuz GM, Manssourian A "Carbamazepine-induced hyponatremia: assessment of risk factors." Ann Pharmacother 39 (2005): 1943-6. [PMID: 16189283]
207	Robson WL, Leung AK "Hyponatraemia following desmopressin." BMJ 307 (1993): 64-5. [PMID: 8343697]
208	Parker WA "Imipramine-induced syndrome of inappropriate antidiuretic hormone secretion." Drug Intell Clin Pharm 18 (1984): 890-4. [PMID: 6499653]
209	Ananth J, Lin KM "Siadh: a serious side effect of psychotropic drugs." Int J Psychiatry Med 16 (1986): 401-7. [PMID: 3557811]
210	Rider JM, Mauger TF, Jameson JP, Notman DD "Water handling in patients receiving haloperidol decanoate." Ann Pharmacother 29 (1995): 663-6. [PMID: 8520076]
211	O'Regan S, Carson S, Chesney RW, Drummond KN "Electrolyte and acid-base disturbances in the management of leukemia." Blood 49 (1977): 345-53. [PMID: 264790]
212	Wylie KR, Harris SJ, Harrop FM "Lofepramine-induced hyponatraemia." Br J Psychiatry 154 (1989): 419-20. [PMID: 2597851]
213	Woo MH, Smythe MA "Association of SIADH with selective serotonin reuptake inhibitors." Ann Pharmacother 31 (1997): 108-10. [PMID: 8997475]
214	Draper B, Berman K "Tolerability of selective serotonin reuptake inhibitors: issues relevant to the elderly." Drugs Aging 25 (2008): 501-19. [PMID: 18540689]
215	Non-steroidal anti-inflammatory drugs and the kidney. Br Med J (Clin Res Ed) 293 (1986): 202-3. [PMID: 3089448]
216	Garcia M, Miller M, Moses AM "Chlorpropamide-induced water retention in patients with diabetes mellitus." Ann Intern Med 75 (1971): 549-54. [PMID: 5094069]
217	Woster P, Carrazana EJ "Oxcarbazepine and hyponatremia." Am J Health Syst Pharm 59 (2002): 467. [PMID: 11887415]
218	Jackson C, Carson W, Markowitz J, Mintzer J "SIADH associated with fluoxetine and sertraline therapy." Am J Psychiatry 152 (1995): 809-10. [PMID: 7726326]
219	Bissett D Cornford EJ Sokal M "Hyponatraemia following cisplatin chemotherapy." Acta Oncol 28 (1989): 823. [PMID: 2611035]
220	Matuk F, Kalyanaraman K "Inappropriate ADH secretion." Arch Neurol 34 (1977): 725. [PMID: 911246]
221	Kato A, Sugiura T, Yamamoto T, et al "Water intoxication induced by low-dose oral cyclophosphamide in a patient with anti-neutrophil cytoplasmic antibody-related glomerulonephritis." NDT Plus 1 (2008): 286-8. [PMID: 18795141]
222	Flint AJ, Crosby J, Genik JL "Recurrent hyponatremia associated with fluoxetine and paroxetine." Am J Psychiatry 153 (1996): 134. [PMID: 8540575]
223	Leung M, Remick R "Sertraline-associated hyponatremia." Can J Psychiatry 40 (1995): 497-8. [PMID: 8681276]
224	Bluff DD, Oji N "SIADH in a patient receiving sertraline." Ann Intern Med 123 (1995): 811. [PMID: 7574211]
225	Otsuka F, Hayashi Y, Ogura T, et al "Syndrome of inappropriate secretion of antidiuretic hormone following intra-thoracic cisplatin." Intern Med 35 (1996): 290-4. [PMID: 8739784]
226	Nagappa M, Bhat RR, Sudeep K, Mishra SK, Badhe AS, Hemavathi B "Vincrisitine-induced acute life-threatening hyponatremia resulting in seizure and coma." Indian J Crit Care Med 13 (2009): 167-8. [PMID: 20040817]
227	DeFronzo RA, Colvin OM, Braine H, Robertson GL, Davis PJ "Proceedings: cyclophosphamide and the kidney." Cancer 33 (1974): 483-91. [PMID: 4812765]
228	Baliga RR, McHardy KC. Syndrome of inappropriate antidiuretic hormone secretion due to fluvoxamine therapy [published correction appears in Br J Clin Pract 1993 May-Jun;47(3):119].?Br J Clin Pract. 1993;47(2):62-63. [PMID: 8334062]
229	Lane RM "SSRIs and hyponatraemia." Br J Clin Pract 51 (1997): 144-6. [PMID: 9293054]
230	Zavagli G Ricci G Tataranni G Mapelli G Abbasciano V "Life-threatening hyponatremia caused by vinblastine." Med Oncol Tumor Pharmacother 5 (1988): 67-9. [PMID: 2452936]
231	Boyd IW "Hyponatremia with venlafaxine." Ann Pharmacother 32 (1998): 981. [PMID: 9762390]
232	Ljung R "Use of desmopressin and concomitant use of potentially interacting drugs in elderly patients in Sweden." Eur J Clin Pharmacol (2008):. [PMID: 18180913]
233	Roxanas MG "Mirtazapine-induced hyponatraemia." Med J Aust 179 (2003): 453-4. [PMID: 14558878]
234	Iyer AV, Krasnow SH, Dufour DR, Arcenas AS "Sodium-wasting nephropathy caused by cisplatin in a patient with small-cell lung cancer." Clin Lung Cancer 5 (2003): 187-9. [PMID: 14667276]
235	Ayonrinde OT, Sanfilippo FM "SSRI antidepressants and SIADH." Aust N Z J Psychiatry 31 (1997): 306-7. [PMID: 9140643]
236	Product Information. Pitressin (vasopressin). Parke-Davis, Morris Plains, NJ.
237	Ritch PS "Cis-dichlorodiammineplatinum II-induced syndrome of inappropriate secretion of antidiuretic hormone." Cancer 61 (1988): 448-50. [PMID: 2827877]
238	Hwang AS, Magraw RM "Syndrome of inappropriate secretion of antidiuretic hormone due to fluoxetine." Am J Psychiatry 146 (1989): 399. [PMID: 2784038]
239	Davison P, Wardrope J "Acute amitriptyline withdrawal and hyponatraemia. A case report." Drug Saf 8 (1993): 78-80. [PMID: 8471189]
240	Thornton SL, Resch DS "SIADH associated with sertraline therapy." Am J Psychiatry 152 (1995): 809. [PMID: 7726325]
241	Stuart MJ, Cuaso C, Miller M, Oski FA "Syndrome of recurrent increased secretion of antidiuretic hormone following multiple doses of vincristine." Blood 45 (1975): 315-20. [PMID: 1054263]
242	Aasen G, Frey HM "Excessive sensitivity to the hyponatremic effect of chlorpropamide in a patient with diabetes mellitus and anterior pituitary insufficiency." Acta Med Scand 208 (1980): 233-6. [PMID: 7435266]
243	Masood GR, Karki SD, Patterson WR "Hyponatremia with venlafaxine." Ann Pharmacother 32 (1998): 49-51. [PMID: 9475820]
244	Moses AM, Howanitz J, van Gemert M, Miller M "Clofibrate-induced antidiuresis." J Clin Invest 52 (1973): 535-42. [PMID: 4685079]
245	Zawada ET "Renal consequences of nonsteroidal antiinflammatory drugs." Postgrad Med J 71 (1982): 223-30. [PMID: 7041104]
246	Harlow PJ, DeClerck YA, Shore NA, Ortega JA, Carranza A, Heuser E "A fatal case of inappropriate ADH secretion induced by cyclophosphamide therapy." Cancer 44 (1979): 896-8. [PMID: 476599]
247	Van Amelsvoort T, Bakshi R, Devaux CB, Schwabe S "Hyponatremia associated with carbamazepine and oxcarbazepine therapy: a review." Epilepsia 35 (1994): 181-8. [PMID: 8112243]
248	Shang CY, Soong WT, Lin HN "Hypokalemia with venlafaxine." J Clin Psychiatry 63 (2002): 1049-50. [PMID: 12469691]
249	Product Information. Stimate (desmopressin). Forest Pharmaceuticals, St. Louis, MO.
250	Cinotti GA, Stirati G, Ruggiero F "Abnormal water retention and symptomatic hyponatraemia in idiopathic diabetes insipidus during chlorpropamide therapy." Postgrad Med J 48 (1972): 107-11. [PMID: 5015114]
251	Henkin Y, Kaplan Z, Alkan M "Psychiatric presentation of hyponatremia associated with the use of amitriptyline: a report of two cases." Isr J Med Sci 25 (1989): 587-9. [PMID: 2807860]
252	Colgate R "Hyponatraemia and inappropriate secretion of antidiuretic hormone associated with the use of imipramine." Br J Psychiatry 163 (1993): 819-22. [PMID: 8306129]
253	Canadian Pharmacists Association.
254	Nisbet P "Chlorpropamide-induced hyponatraemia." Br Med J 1 (1977): 904. [PMID: 851776]
255	Adlakha A, Manocha AP, Bechard DL "Imipramine-induced syndrome of inappropriate antidiuretic hormone secretion." South Med J 84 (1991): 1507-9. [PMID: 1749990]
256	Kessler J, Samuels SC "Sertraline and hyponatremia." N Engl J Med 335 (1996): 524. [PMID: 8676965]
257	Twardowschy CA, Bertolucci CB, Gracia Cde M, Brandao MA "Severe hyponatremia and the syndrome of inappropriate secretion of antidiuretic hormone (SIADH) associated with fluoxetine: case report." Arq Neuropsiquiatr 64 (2006): 142-5. [PMID: 16622573]
258	Zalin AM, Hutchinson CE, Jong M, Matthews K "Hyponatraemia during treatment with chlorpropamide and Moduretic (amiloride plus hydrochlorothiazide)." Br Med J (Clin Res Ed) 289 (1984): 659. [PMID: 6434028]
259	Berg MJ, Fischer LJ, Rivey MP, Vern BA, Lantz RK, Schottelius DD "Phenytoin and folic acid interaction: a preliminary report." Ther Drug Monit 5 (1983): 389-94. [PMID: 6659012]
260	Katz M "Potential danger of self-medication with folic acid." N Engl J Med 289 (1973): 1095. [PMID: 4742232]
261	Furlanut M, Benetello P, Avogaro A, Dainese R "Effects of folic acid on phenytoin kinetics in healthy subjects." Clin Pharmacol Ther 24 (1978): 294-7. [PMID: 688723]
262	Product Information. Apokyn (apomorphine). Mylan Pharmaceuticals Inc, Morgantown, WV.
263	Product Information. Zohydro ER (HYDROcodone). Zogenix, Inc, San Diego, CA.
264	Product Information. Zulresso (brexanolone). Sage Therapeutics, Inc., Cambridge, MA.
265	American Epilepsy Society "FDA Safety Warning on the Cardiac Effects of Lamotrigine: An Advisory from the Ad Hoc ILAE/AES Task Force. [PMID: 33641454]
266	French JA, Perucca E, Sander JW, et al. FDA safety warning on the cardiac effects of lamotrigine: An advisory from the Ad Hoc ILAE/AES Task Force.?Epilepsia Open. 2021;6(1):45-48. [PMID: 33681647]
267	Bottiger Y, Svensson JO, Stahle L "Lamotrigine drug interactions in a TDM material." Ther Drug Monit 21 (1999): 171-4. [PMID: 10217336]
268	Jawad S, Richens A, Goodwin G, Yuen WC "Controlled trial of lamotrigine (Lamictal) for refractory partial seizures." Epilepsia 30 (1989): 356-63. [PMID: 2498073]
269	Koch HJ, Szecsey A, Vogel M "Clinically relevant reduction of lamotrigine concentrations by carbamazepine." Eur Psychiatry 18 (2003): 42. [PMID: 12648898]
270	Patsalos PN, Perucca E "Clinically important drug interactions in epilepsy: interactions between antiepileptic drugs and other drugs." Lancet Neurol 2 (2003): 473-81. [PMID: 12878435]
271	Pisani F, Xiao B, Fazio A, Spina E, Perucca E, Tomson T "Single dose pharmacokinetics of carbamazepine-10,11-epoxide in patients on lamotrigine monotherapy." Epilepsy Res 19 (1994): 245-8. [PMID: 7698101]
272	Reimers A, Skogvoll E, Sund JK, Spigset O "Drug Interactions Between Lamotrigine and Psychoactive Drugs: Evidence From a Therapeutic Drug Monitoring Service." J Clin Psychopharmacol 25 (2005): 342-348. [PMID: 16012277]
273	Spina E, Pisani F, Perucca E "Clinically significant pharmacokinetic drug interactions with carbamazepine - an update." Clin Pharmacokinet 31 (1996): 198-214. [PMID: 8877250]
274	Subuh Surja AA, Brotzge KE, El-Mallakh RS "Serious rash with lamotrigine after carbamazepine discontinuation: a case report." J Clin Psychiatry 66 (2005): 400-401. [PMID: 15766317]
275	Warner T, Patsalos PN, Prevett M, Elyas AA, Duncan JS "Lamotrigine-induced carbamazepine toxicity: an interaction with carbamazepine-10,11-epoxide." Epilepsy Res 11 (1992): 147-50. [PMID: 1618180]
276	Product Information. Aralen (chloroquine). Sanofi Winthrop Pharmaceuticals, New York, NY.
277	Product Information. Hydroxychloroquine Sulfate (hydroxychloroquine). Prasco Laboratories, Cincinnati, OH.
278	Product Information. Plaquenil (R). (hydroxychloroquine). Sanofi Winthrop Pharmaceuticals, New York, NY.
279	Product Information. Welchol (colesevelam) Daiichi Sankyo, Inc., Parsippany, NJ.
280	EMEA. European Medicines Agency "EPARs. European Union Public Assessment Reports.".
281	Cerner Multum, Inc "ANVISA Bulario Eletrnico." .
282	Product Information. Spravato (esketamine). Janssen Pharmaceuticals, Titusville, NJ.
283	Warrington SJ, Ankier SI, Turner P "Evaluation of possible interactions between ethanol and trazodone or amitriptyline." Neuropsychobiology 15 (1986): 31-7. [PMID: 3725002]
284	Gilman AG, Rall TW, Nies AS, Taylor P, eds. "Goodman and Gilman's the Pharmacological Basis of Therapeutics. 8th ed." New York, NY: Pergamon Press Inc. (1990):.
285	Product Information. Rexulti (brexpiprazole). Otsuka American Pharmaceuticals Inc, Rockville, MD.
286	Product Information. Fycompa (perampanel). Eisai Inc, Teaneck, NJ.
287	Product Information. Addyi (flibanserin). Sprout Pharmaceuticals, Raleigh, NC.
288	Patsalos PN, Perucca E "Clinically important drug interactions in epilepsy: general features and interactions between antiepileptic drugs." Lancet Neurol 2 (2003): 347-56. [PMID: 12849151]
289	Miller LG "Herbal medicinals: selected clinical considerations focusing on known or potential drug-herb interactions." Arch Intern Med 158 (1998): 2200-11. [PMID: 9818800]
290	Harms SL, Garrard J, Schwinghammer P, Eberly LE, Chang Y, Leppik IE "Ginkgo biloba use in nursing home elderly with epilepsy or seizure disorder." Epilepsia 47 (2006): 323-9. [PMID: 16499756]
291	Kupiec T, Raj V "Fatal seizures due to potential herb-drug interactions with Ginkgo biloba." J Anal Toxicol 29 (2005): 755-8. [PMID: 16419414]
292	Product Information. Reyvow (lasmiditan). Lilly, Eli and Company, Indianapolis, IN.
293	Product Information. Kaletra (lopinavir-ritonavir) Abbott Pharmaceutical, Abbott Park, IL.
294	Product Information. Patanase (olopatadine nasal). Alcon Laboratories Inc, Fort Worth, TX.
295	Bigham S, McGuigan C, MacDonald BK "Reduced absorption of lipophilic anti-epileptic medications when used concomitantly with the anti-obesity drug orlistat." Epilepsia 47 (2006): 2207. [PMID: 17201727]
296	Product Information. Xenical (orlistat). Roche Laboratories, Nutley, NJ.
297	Product Information. Cylert (pemoline). Abbott Pharmaceutical, Abbott Park, IL.
298	Blakely KM, Drucker AM, Rosen CF "Drug-induced photosensitivity-an update: Culprit drugs, prevention and management." Drug Saf 42 (2019): 827-47. [PMID: 30888626]
299	Product Information. Photofrin (porfimer). Sanofi Winthrop Pharmaceuticals, New York, NY.
300	Ebert U, Thong NQ, Oertel R, Kirch W "Effects of rifampicin and cimetidine on pharmacokinetics and pharmacodynamics of lamotrigine in healthy subjects." Eur J Clin Pharmacol 56 (2000): 299-304. [PMID: 10954343]
301	Product Information. Thalomid (thalidomide). Celgene Corporation, Warren, NJ.
302	Product Information. Zanaflex (tizanidine). Acorda Therapeutics, Hawthorne, NY.
303	Lambertsen CJ, Wendel H, Longenhagen JB "The separate and combined respiratory effects of chlorpromazine and meperidine in normal men controlled at 46 mm Hg alveolar pCO2." J Pharmacol Exp Ther 131 (1961): 381-93. [PMID: 13758472]
304	Hoffman JC, Smith TC "The respiratory effects of meperidine and propiomazine in man." Anesthesiology 32 (1970): 325-31. [PMID: 4392394]
305	Stambaugh JE, Wainer IW "Drug interaction: meperidine and chlorpromazine, a toxic combination." J Clin Pharmacol 21 (1981): 140-6. [PMID: 7240435]
306	Product Information. Meperidine Hydrochloride Injection, USP (meperidine) Astra-Zeneca Pharmaceuticals, Wilmington, DE.
307	Product Information. Demerol (meperidine). Sanofi Winthrop Pharmaceuticals, New York, NY.

Details of Drug

Details of Drug

Cite MecDDI

About MecDDI

Correspondence